Home Adaptation of the behaviour of an aspartic proteinase inhibitor by relocation of a lysine residue by one helical turn
Article
Licensed
Unlicensed Requires Authentication

Adaptation of the behaviour of an aspartic proteinase inhibitor by relocation of a lysine residue by one helical turn

  • Tim J. Winterburn , David M. Wyatt , Lowri H. Phylip , Colin Berry , Daniel Bur and John Kay
Published/Copyright: August 9, 2006
Biological Chemistry
From the journal Volume 387 Issue 8

Abstract

In addition to self-inhibition of aspartic proteinase zymogens by their intrinsic proparts, the activity of certain members of this enzyme family can be modulated through active-site occupation by extrinsic polypeptides such as the small IA3 protein from Saccharomyces cerevisiae. The unprecedented mechanism by which IA3 helicates to inhibit its sole target aspartic proteinase locates an i, i+4 pair of charged residues (Lys18+Asp22) on an otherwise-hydrophobic face of the amphipathic helix. The nature of these residues is not crucial for effective inhibition, but re-location of the lysine residue by one turn (+4 residues) in the helical IA3 positions its side chain in the mutant IA3-proteinase complex in an orientation essentially identical to that of the key lysine residue in zymogen proparts. The binding of the extrinsic mutant IA3 shows pH dependence reminiscent of that required for the release of intrinsic zymogen proparts so that activation can occur.

:

Corresponding author

References

Bernstein, N.K., Cherney, M.M., Loetscher, H., Ridley, R.G., and James, M.N.G. (1999). Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from P. falciparum. Nat. Struct. Biol.6, 32–37.Search in Google Scholar

Brik, A. and Wong, C.-H. (2003). HIV-1 protease: mechanism and drug discovery. Org. Biomol. Chem.1, 5–14.10.1039/b208248aSearch in Google Scholar

Dunn, B.M. (2002). Structure and mechanism of the pepsin-like family of aspartic peptidases. Chem. Rev.102, 4431–4458.10.1021/cr010167qSearch in Google Scholar

Green, T., Ganesh, O., Perry, K., Smith, L., Phylip, L.H., Logan, T.M., Hagen, S.J., Dunn, B.M., and Edison, A.S. (2004). IA3, an aspartic proteinase inhibitor from Saccharomyces cerevisiae, is intrinsically unstructured in solution. Biochemistry43, 4071–4081.10.1021/bi034823nSearch in Google Scholar

Gribouval, O., Gonzales, M., Neuhaus, T., Aziza, J., Bieth, E., Laurent, N., Bouton, J.M., Feuillet, F., Makni, S., Amar, H.B., et al. (2005). Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat. Genet.37, 964–968.10.1038/ng1623Search in Google Scholar

Khan, A.R. and James, M.N.G. (1998). Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci.7, 815–836.10.1002/pro.5560070401Search in Google Scholar

Lee, A.Y., Gulnik, S.V., and Erickson, J.W. (1998). Conformational switching in an aspartic proteinase. Nat. Struct. Biol.5, 866–870.10.1038/2306Search in Google Scholar

Li, M., Phylip, L.H., Lees, W.E., Winther, J.R., Dunn, B.M., Wlodawer, A., Kay, J., and Gustchina, A. (2000). The aspartic proteinase from Saccharomyces cerevisiae folds its own inhibitor into a helix. Nat. Struct. Biol.7, 113–117.Search in Google Scholar

Moore, S.A., Sielecki, A.R., Chernaia, M.M., Tarasova, N.I., and James, M.N.G. (1995). Crystal and molecular structures of human progastricsin at 1.62 Å resolution. J. Mol. Biol.247, 466–485.Search in Google Scholar

Ng, K.K.S., Petersen, J.F.W., Cherney, M.M., Garen, C., Zalatoris, J.J., Rao-Naik, C., Dunn, B.M., Martzen, M.R., Peanasky, R.J., and James, M.N.G. (2000). Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3. Nat. Struct. Biol.7, 653–657.10.1038/77950Search in Google Scholar

Oefner, C., Binggeli, A., Breu, V., Bur, D., Clozel, J.-P., D'Arcy, A., Dorn, A., Fischli, W., Gruninger, F., Guller, R., et al. (1999). Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases? Chem. Biol.6, 127–131.10.1016/S1074-5521(99)89004-8Search in Google Scholar

Phylip, L.H., Lees, W.E., Brownsey, B.G., Bur, D., Dunn, B.M., Winther, J.R., Gustchina, A., Li, M., Copeland, T., Wlodawer, A., and Kay, J. (2001). The potency and specificity of the interaction between IA3 and its target aspartic proteinase. J. Biol. Chem.276, 2023–2030.10.1074/jbc.M008520200Search in Google Scholar PubMed

ten Have, A., Dekkers, E., Kay, J., Phylip, L.H., and van Kan, J.A.L. (2004). An aspartic proteinase gene family in the filamentous fungus Botrytis cinerea contains members with novel features. Microbiology150, 2475–2489.Search in Google Scholar

Tigue, N.J. and Kay, J. (1998). Autoprocessing and peptide substrates for human herpesvirus 6 proteinase. J. Biol. Chem.273, 26441–26446.10.1074/jbc.273.41.26441Search in Google Scholar PubMed

Wood, J.M., Maibaum, J., Rahuel, J., Grutter, M.G., Cohen, N-C., Rasetti, V., Ruger, H., Goschke, R., Stutz, S., Fuhrer, W., et al. (2003). Structure-based design of aliskiren, a novel orally effective renin inhibitor. Biochem. Biophys. Res. Commun.308, 698–705.10.1016/S0006-291X(03)01451-7Search in Google Scholar

Published Online: 2006-08-09
Published in Print: 2006-08-01

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Caspase-containing complexes in the regulation of cell death and inflammation
  2. Regulation of human cathepsin B by alternative mRNA splicing: homeostasis, fatal errors and cell death
  3. The peptidases from fungi and viruses
  4. C. elegans as a model system to study the function of the COG complex in animal development
  5. Functional responses of bone cells to thrombin
  6. Homologous substitution of ACE C-domain regions with N-domain sequences: effect on processing, shedding, and catalytic properties
  7. Production and processing of a recombinant Fasciola hepatica cathepsin B-like enzyme (FhcatB1) reveals potential processing mechanisms in the parasite
  8. Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata
  9. Single-cell resolution imaging of membrane-anchored hepatitis C virus NS3/4A protease activity
  10. Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS
  11. Proteolytic mechanism of a novel mitochondrial and chloroplastic PreP peptidasome
  12. Tripeptidyl-peptidase I in health and disease
  13. Molecular and functional analysis of new members of the wheat PR4 gene family
  14. C-Terminal truncations of syncytin-1 (ERVWE1 envelope) that increase its fusogenicity
  15. Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma
  16. Heparin modulation of human plasma kallikrein on different substrates and inhibitors
  17. Adaptation of the behaviour of an aspartic proteinase inhibitor by relocation of a lysine residue by one helical turn
  18. Cathepsins L and S are not required for activation of dipeptidyl peptidase I (cathepsin C) in mice
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2006.140/html
Scroll to top button